Your Top 100 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
LBA53 Nivolumab (NIVO) plus relatlimab with platinum-doublet chemotherapy (PDCT) vs NIVO + PDCT as first-line (1L) treatment (tx) for stage IV or recurrent NSCLC: Results from the randomized phase II RELATIVITY-104 study
Nicolas Girard, Mauricio Burotto, Luiz Paz-Ares, Martin Reck, M. Schenker, A. Lingua and 12 more
- Rank
- 97 of 3,853
- Percentile
- top 2.6%
- Where
- Annals of Oncology, 2024
- Citations
- 22
From the 2024 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.